跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71,772 条关于
“Substance P/Neurokinin-1 Receptor”
全部
71,772
临床试验
42,367
药物
8,911
机构
1,481
资讯
19,013
去年
Hoth Therapeutics Receives US Patent for HT-ALZ, a Novel Alzheimer's Treatment
去年
Heron Therapeutics Settles Patent Litigation with Mylan for CINVANTI and APONVIE
去年
Eolas Therapeutics Assumes Full Development Rights to First-in-Class Orexin-1 Receptor Antagonist AZD4041 for Substance Use Disorders
9个月前
Baseline Therapeutics Launches with Novel GLP-1 Approach for Substance Use Disorders
5个月前
Vanda Pharmaceuticals Initiates Thetis Trial Testing NEREUS for GLP-1 Receptor Agonist-Induced Vomiting
2年前
PD-1 Blockades Show Feasibility and Tolerability in Elderly Patients with Metastatic Esophageal Squamous Cell Carcinoma
去年
AskBio Completes Enrollment in Phase 1 Gene Therapy Trial for Rare Neurological Disease MSA-P
3年前
Quanterix Launches Novel P-Tau 205 and P-Tau 212 Assays to Advance Alzheimer's Research
去年
GLP-1 Receptor Agonists Not Linked to Increased Suicide Risk, Study Finds
去年
Anti-Nausea Drug Aprepitant Shows Significant Survival Benefits in Triple-Negative Breast Cancer
第 1 页，共 1902 页
上一页
下一页
